IL91814A0 - Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparation - Google Patents

Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparation

Info

Publication number
IL91814A0
IL91814A0 IL91814A IL9181489A IL91814A0 IL 91814 A0 IL91814 A0 IL 91814A0 IL 91814 A IL91814 A IL 91814A IL 9181489 A IL9181489 A IL 9181489A IL 91814 A0 IL91814 A0 IL 91814A0
Authority
IL
Israel
Prior art keywords
pteridines
group
preparation
substituted
carbon atom
Prior art date
Application number
IL91814A
Other versions
IL91814A (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL91814A0 publication Critical patent/IL91814A0/en
Publication of IL91814A publication Critical patent/IL91814A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to medicaments containing a pteridine of the formula <IMAGE> in which n is the number 0 or 1, R2 and R7 are each a pyrrolidino, piperidino or morpholino group which is optionally substituted by one or two methyl groups, R3 is a straight-chain or branched alkyl group in which one or two carbon atoms, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, R<4> is an alkyl or phenylalkyl group, in which one carbon atom, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, and R5 is a hydrogen atom or a methyl group, or the acid addition salts thereof and at least one chemotherapeutic from the natural product series, and to the use of the above pteridines for sensitisation of tumours during chemotherapy with the abovementioned chemotherapeutics, and to pteridines, process for the preparation thereof and medicaments containing these pteridines.
IL9181489A 1988-10-01 1989-09-28 Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation IL91814A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (en) 1988-10-01 1988-10-01 USE OF PTERIDINES TO PREVENT PRIMARY AND SECONDARY RESISTANCE IN CHEMOTHERAPY AND MEDICINES CONTAINING THESE COMPOUNDS

Publications (2)

Publication Number Publication Date
IL91814A0 true IL91814A0 (en) 1990-06-10
IL91814A IL91814A (en) 1994-02-27

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9181489A IL91814A (en) 1988-10-01 1989-09-28 Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation

Country Status (19)

Country Link
EP (1) EP0362645B1 (en)
JP (1) JPH02256676A (en)
KR (1) KR910006289A (en)
AT (1) ATE106728T1 (en)
AU (1) AU620645B2 (en)
DD (1) DD299062A5 (en)
DE (2) DE3833393A1 (en)
DK (1) DK480489A (en)
ES (1) ES2056174T3 (en)
FI (1) FI92699C (en)
HU (1) HU205761B (en)
IL (1) IL91814A (en)
MX (1) MX9203034A (en)
NO (1) NO175979C (en)
NZ (1) NZ230833A (en)
PT (1) PT91836B (en)
SU (1) SU1720491A3 (en)
UA (1) UA8028A1 (en)
ZA (1) ZA897414B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533464A (en) * 1998-12-28 2002-10-08 カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント Immunosuppressive effects of pteridine derivatives
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (en) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridine derivatives, process for their preparation and their use
AU2004271721A1 (en) * 2003-09-12 2005-03-24 4 Aza Bioscience Nv Pteridine derivatives for the treatment of septic shock and TNF-alpha-related diseases.
AU2004283479A1 (en) * 2003-10-17 2005-05-06 4 Aza Bioscience Nv Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (en) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Pteridines effective as hcv inhibitors and methods for producing pteridines
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
CU20180011A7 (en) 2015-03-04 2018-06-05 Gilead Sciences Inc PHARMACEUTICAL COMPOSITIONS THAT INCLUDE COMPOUNDS DERIVED FROM DIAMINOPIRED (3,2-D) AS TOLL TYPE RECEIVER MODULATORS
KR20160003575A (en) 2015-11-09 2016-01-11 정민시 Power transmitting apparatus for generator
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
PL3507276T3 (en) 2016-09-02 2022-02-21 Gilead Sciences, Inc. Toll like receptor modulator compounds
TWI751516B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI751517B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TW202115056A (en) 2019-06-28 2021-04-16 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (en) * 1966-10-14
DE1617336C2 (en) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Medicines for angina pectoris
DE1795515A1 (en) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Process for the production of new pteridines
DE1795516A1 (en) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2- (2'-methylmorpholino) -7-morpholino-6-phenyl-pteridine
DE1921308A1 (en) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Pharmaceutical prepns. containing one or more of cpds. of general formula (I):- ArOCH2 - CHOH - CH2 - NHR (I) Ar= opt. mono-or polysubstd. iso-, hom
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
MX9203034A (en) 1992-07-01
IL91814A (en) 1994-02-27
NO893879D0 (en) 1989-09-29
ES2056174T3 (en) 1994-10-01
ZA897414B (en) 1991-06-26
NZ230833A (en) 1991-05-28
UA8028A1 (en) 1995-12-26
DK480489D0 (en) 1989-09-29
DK480489A (en) 1990-04-02
EP0362645A3 (en) 1992-03-25
DE3833393A1 (en) 1990-04-05
KR910006289A (en) 1991-04-29
FI92699B (en) 1994-09-15
EP0362645B1 (en) 1994-06-08
HU205761B (en) 1992-06-29
AU620645B2 (en) 1992-02-20
FI894615A0 (en) 1989-09-29
NO893879L (en) 1990-04-02
DE58907824D1 (en) 1994-07-14
HUT52504A (en) 1990-07-28
EP0362645A2 (en) 1990-04-11
AU4174989A (en) 1990-04-05
DD299062A5 (en) 1992-03-26
PT91836A (en) 1990-04-30
NO175979B (en) 1994-10-03
FI894615A (en) 1990-04-02
ATE106728T1 (en) 1994-06-15
JPH02256676A (en) 1990-10-17
NO175979C (en) 1995-01-11
FI92699C (en) 1994-12-27
PT91836B (en) 1995-07-18
SU1720491A3 (en) 1992-03-15

Similar Documents

Publication Publication Date Title
IL91814A0 (en) Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparation
NZ218786A (en) 1,4 disubstituted piperidine derivatives and pharmaceutical compositions
ES8305356A1 (en) Carbostyril derivatives and pharmaceutical composition containing the same
HRP940524A2 (en) Therapeutic heterocyclic compounds
ES8301927A1 (en) Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them.
ES8707238A1 (en) Pteridines, process for their preparation, and their use as intermediates or as medicaments.
ES8307743A1 (en) 3-Hydroxypyrrolidin-2-one derivatives, process and intermediates for their preparation and pharmaceutical preparations containing them.
ES390924A1 (en) Esters of substituted nicotine acids
GB1084150A (en)
ES345993A1 (en) 2-(di - (beta-hydroxy-lower alkyl)amino)-4,7-di - (heterocyclic amino) - 6 - phenyl-pteridines
GB1512101A (en) Piperazinopyrimidines process for their preparation and use
ES345992A1 (en) 2,7-di-(heterocyclic amino)-4-amino-6-phenyl-pteridines
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
GB1262052A (en) Dibenzofuran derivatives
GB1341170A (en) Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES485333A1 (en) 5,6,7,8-Tetrahydro-4(3H)- quinazolinone derivatives useful as spasmolytics
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
MY101502A (en) Substituted benzymidazole derivatives, process from their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void